IN VIVO STUDIES CORE DEFINITION The objective of the In Vivo Studies Core is to provide a venue for focusing the human resources, facilities, new technology and equipment necessary for in vivo study of humans and animals. The Core serves to fully integrate investigations at the molecular, cellular and organ system level that are currently performed within the other Cores of the Center. The Core is organized to bring together expertise and in vivo techniques from different disciplines to investigate the role of peptide hormones in a wide variety of gastrointestinal functions. Toward these goals, the major services provided by the In Vivo Studies Core are as follows: 1. To make available a wide variety of acute and chronic animal models for in vivo evaluation of the biological actions of peptide hormones. 2. To examine the physiological changes in mouse models following transgene expression or gene mutation. 3. To provide various in vivo techniques and tests for the investigation of the physiology and pathophysiology of gastrointestinal peptides in man. 4. To facilitate innovations in methodology and to develop new and sophisticated techniques for in vivo studies. 5. To provide education and consultation on the application of in vivo techniques so that basic physiological and biochemical questions pertaining to peptide hormones may be answered.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK034933-23
Application #
7727017
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2007-12-01
Budget End
2008-11-30
Support Year
23
Fiscal Year
2008
Total Cost
$183,517
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Wang, Xuexiang; Dande, Ranadheer R; Yu, Hao et al. (2018) TRPC5 Does Not Cause or Aggravate Glomerular Disease. J Am Soc Nephrol 29:409-415
Bhattacharya, Asmita; Sun, Shengyi; Wang, Heting et al. (2018) Hepatic Sel1L-Hrd1 ER-associated degradation (ERAD) manages FGF21 levels and systemic metabolism via CREBH. EMBO J 37:
Perry, Jeffrey W; Tai, Andrew W (2018) Random Insertional Mutagenesis of a Serotype 2 Dengue Virus Clone. Bio Protoc 8:
El-Zaatari, Mohamad; Bass, Adam J; Bowlby, Reanne et al. (2018) Indoleamine 2,3-Dioxygenase 1, Increased in Human Gastric Pre-Neoplasia, Promotes Inflammation and Metaplasia in Mice and Is Associated With Type II Hypersensitivity/Autoimmunity. Gastroenterology 154:140-153.e17
Sze, Marc A; Schloss, Patrick D (2018) Leveraging Existing 16S rRNA Gene Surveys To Identify Reproducible Biomarkers in Individuals with Colorectal Tumors. MBio 9:
Schofield, Heather K; Tandon, Manuj; Park, Min-Jung et al. (2018) Pancreatic HIF2? Stabilization Leads to Chronic Pancreatitis and Predisposes to Mucinous Cystic Neoplasm. Cell Mol Gastroenterol Hepatol 5:169-185.e2
Jiang, Lin; Su, Haoran; Keogh, Julia M et al. (2018) Neural deletion of Sh2b1 results in brain growth retardation and reactive aggression. FASEB J 32:1830-1840
Namkoong, Sim; Ho, Allison; Woo, Yu Mi et al. (2018) Systematic Characterization of Stress-Induced RNA Granulation. Mol Cell 70:175-187.e8
Han, Xu; Lee, Allen; Huang, Sha et al. (2018) Lactobacillus rhamnosus GG prevents epithelial barrier dysfunction induced by interferon-gamma and fecal supernatants from irritable bowel syndrome patients in human intestinal enteroids and colonoids. Gut Microbes :1-18
Hannigan, Geoffrey D; Duhaime, Melissa B; Koutra, Danai et al. (2018) Biogeography and environmental conditions shape bacteriophage-bacteria networks across the human microbiome. PLoS Comput Biol 14:e1006099

Showing the most recent 10 out of 757 publications